Literature DB >> 24055030

MUC1 activates JNK1 and inhibits apoptosis under genotoxic stress.

Qiongqiong Chen1, Decai Li, Jian Ren, Chenghua Li, Zhi-Xiong Xiao.   

Abstract

The MUC1 transmembrane glycoprotein is aberrantly overexpressed in diverse human carcinomas and has been shown to inhibit apoptosis induced by genotoxic agents. In the present work, we report that MUC1 binds to and activates JNK1, an important member of the mitogen-activated protein kinases (MAPK) superfamily. The physical interaction between MUC1 cytoplasmic domain (MUC1-CD) and JNK1 was established by GST-pull-down assay in vitro and co-immunoprecipitation assay in vivo. We show that MUC1 activates JNK1 and inhibits cisplatin-induced apoptosis in human colon cancer HCT116 cells. Pharmacological inhibition of JNK or knockdown of JNK significantly reduces the ability of MUC1 to inhibit cisplatin-induced apoptosis. Together, our data indicate that MUC1 can inhibit apoptosis via activating JNK1 pathway in response to genotoxic anticancer agents.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; DNA damage; JNK; MUC1

Mesh:

Substances:

Year:  2013        PMID: 24055030     DOI: 10.1016/j.bbrc.2013.09.055

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

Review 1.  Role of C-Jun N-terminal Kinase in Hepatocellular Carcinoma Development.

Authors:  Juan Wang; Guixiang Tai
Journal:  Target Oncol       Date:  2016-12       Impact factor: 4.493

2.  SLC27A4 regulate ATG4B activity and control reactions to chemotherapeutics-induced autophagy in human lung cancer cells.

Authors:  Shifei Wu; Jie Su; Hui Qian; Tao Guo
Journal:  Tumour Biol       Date:  2015-12-11

3.  Mucin 1 promotes radioresistance in hepatocellular carcinoma cells through activation of JAK2/STAT3 signaling.

Authors:  Feng-Tao Yi; Qi-Ping Lu
Journal:  Oncol Lett       Date:  2017-10-03       Impact factor: 2.967

4.  Mucin1 shifts Smad3 signaling from the tumor-suppressive pSmad3C/p21(WAF1) pathway to the oncogenic pSmad3L/c-Myc pathway by activating JNK in human hepatocellular carcinoma cells.

Authors:  Qiongshu Li; Guomu Liu; Hongyan Yuan; Juan Wang; Yingying Guo; Tanxiu Chen; Ruiping Zhai; Dan Shao; Weihua Ni; Guixiang Tai
Journal:  Oncotarget       Date:  2015-02-28

5.  Mucin1 promotes the migration and invasion of hepatocellular carcinoma cells via JNK-mediated phosphorylation of Smad2 at the C-terminal and linker regions.

Authors:  Juan Wang; Guomu Liu; Qiongshu Li; Fang Wang; Fei Xie; Ruiping Zhai; Yingying Guo; Tanxiu Chen; Nannan Zhang; Weihua Ni; Hongyan Yuan; Guixiang Tai
Journal:  Oncotarget       Date:  2015-08-07

6.  Mucin 1 gene silencing inhibits the growth of SMMC-7721 human hepatoma cells through Bax-mediated mitochondrial and caspase-8-mediated death receptor apoptotic pathways.

Authors:  Hongyan Yuan; Juan Wang; Fengli Wang; Nannan Zhang; Qiongshu Li; Fei Xie; Tanxiu Chen; Ruiping Zhai; Fang Wang; Yingying Guo; Weihua Ni; Guixiang Tai
Journal:  Mol Med Rep       Date:  2015-09-14       Impact factor: 2.952

7.  Gene expression changes in tumor free tongue tissue adjacent to tongue squamous cell carcinoma.

Authors:  Linda Boldrup; Xiaolian Gu; Philip J Coates; Lena Norberg-Spaak; Robin Fahraeus; Göran Laurell; Torben Wilms; Karin Nylander
Journal:  Oncotarget       Date:  2017-03-21

8.  Targeting MUC1 and JNK by RNA interference and inhibitor inhibit the development of hepatocellular carcinoma.

Authors:  Juan Wang; Wei-Hua Ni; Ke-Bang Hu; Xiao-Yu Zhai; Fei Xie; Jing Jie; Nan-Nan Zhang; Li-Na Jiang; Hong-Yan Yuan; Gui-Xiang Tai
Journal:  Cancer Sci       Date:  2017-03       Impact factor: 6.716

Review 9.  MUC1: Structure, Function, and Clinic Application in Epithelial Cancers.

Authors:  Wenqing Chen; Zhu Zhang; Shiqing Zhang; Peili Zhu; Joshua Ka-Shun Ko; Ken Kin-Lam Yung
Journal:  Int J Mol Sci       Date:  2021-06-18       Impact factor: 5.923

Review 10.  The role of PAM4 in the management of pancreatic cancer: diagnosis, radioimmunodetection, and radioimmunotherapy.

Authors:  Suxia Han; Guihua Jin; Lijuan Wang; Meng Li; Chenchen He; Xijing Guo; Qing Zhu
Journal:  J Immunol Res       Date:  2014-04-10       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.